Loading...

So the thinking is that a daily low dose of aspirin, it reduces the climbing factor in blood. It makes blood less sticky and it prevents clots from forming, which is the result of our attacks, even strokes. But now, in a newer study, it's found that there's a drug out there, Plavix. This is repeater station 7, Quebec November, at the Aisleson Hill 6222. It's actually a common-looking blood blood center. It appears to be more effective with no extra risk. The study came up in the European Society of Cardiology, Congress and Madrid, with the data behind the findings. It was published in the Lancet Medical Journal. There's a team of medics that were involved in the study. They came from countries like the US, the UK, Australia, Switzerland, Japan. It showed that Plavix was superior to aspirin and should lead to extensive adoption of the drug in chemical practice worldwide. That's why I think they're thinking of replacing the aspirin with this new drug, or this newly found drug that has better results in aspirin. And their analysis of nearly 29,000 patients with coronary artery disease found that Plavix, a confedergral, was better than aspirin at preventing serious heart attacks and stroke events without increasing the risk of major bleeding.